Cytokinetics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11M | 131k | 83.49 |
| 2023-09-30 | $4.9M | 168k | 29.46 |
| 2023-06-30 | $4.0M | 122k | 32.62 |
| 2023-03-31 | $5.9M | 168k | 35.19 |
| 2022-12-31 | $7.4M | 162k | 45.82 |
| 2022-09-30 | $3.1M | 64k | 48.46 |
| 2022-06-30 | $3.7M | 94k | 39.29 |
| 2022-03-31 | $3.1M | 83k | 36.81 |
| 2021-12-31 | $4.5M | 98k | 45.58 |
| 2014-03-31 | $1.5M | 141k | 10.49 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management